EFFECT OF CAPTOPRIL ON PROGRESSIVE TYPE I DIABETIC KIDNEY DISEASE

卡托普利对进展性 I 型糖尿病肾病的影响

• 批准号: 3740487
• 负责人: JACOB LEMANN JR
• 金额: --
• 依托单位: MEDICAL COLLEGE OF WISCONSIN
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3740487
• 关键词: ACE inhibitors; captopril; clinical trials; diabetes mellitus therapy; diabetic nephropathy; enzyme therapy; human subject; human therapy evaluation; insulin dependent diabetes mellitus; kidney function; medical complication; peptidyl dipeptidase A; placebos

This is a multi-hospital, double-blind, placebo controlled collaborative study to determine whether angiotensin-converting enzyme therapy alters the rate of loss of renal function and the outcome in patient with type I diabetes who manifest evidence of diabetic nephropathy.

这是一项多医院、双盲、安慰剂对照的协作研究 确定血管紧张素转换酶疗法是否改变的研究 类型患者的肾功能丧失率和结果 我是糖尿病患者，有糖尿病肾病的证据。